XRF Scientific Statistics

Total Valuation

XRF Scientific has a market cap or net worth of AUD 252.89 million. The enterprise value is 246.19 million.

Market Cap	252.89M
Enterprise Value	246.19M

Important Dates

The next estimated earnings date is Monday, February 17, 2025.

Earnings Date	Feb 17, 2025
Ex-Dividend Date	Sep 12, 2024

Share Statistics

XRF Scientific has 140.49 million shares outstanding. The number of shares has increased by 0.80% in one year.

Current Share Class	n/a
Shares Outstanding	140.49M
Shares Change (YoY)	+0.80%
Shares Change (QoQ)	+0.43%
Owned by Insiders (%)	23.02%
Owned by Institutions (%)	2.21%
Float	91.22M

Valuation Ratios

The trailing PE ratio is 28.13 and the forward PE ratio is 25.35.

PE Ratio	28.13
Forward PE	25.35
PS Ratio	4.13
PB Ratio	4.53
P/TBV Ratio	6.47
P/FCF Ratio	39.04
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.16, with an EV/FCF ratio of 38.00.

EV / Earnings	27.71
EV / Sales	4.10
EV / EBITDA	16.16
EV / EBIT	17.92
EV / FCF	38.00

Financial Position

The company has a current ratio of 3.75, with a Debt / Equity ratio of 0.08.

Current Ratio	3.75
Quick Ratio	2.06
Debt / Equity	0.08
Debt / EBITDA	0.31
Debt / FCF	0.72
Interest Coverage	47.76

Financial Efficiency

Return on equity (ROE) is 18.07% and return on invested capital (ROIC) is 14.85%.

Return on Equity (ROE)	18.07%
Return on Assets (ROA)	12.84%
Return on Capital (ROIC)	14.85%
Revenue Per Employee	1.25M
Profits Per Employee	185,110
Employee Count	48
Asset Turnover	0.90
Inventory Turnover	1.98

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +48.76% in the last 52 weeks. The beta is 0.89, so XRF Scientific's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	+48.76%
50-Day Moving Average	1.74
200-Day Moving Average	1.51
Relative Strength Index (RSI)	49.60
Average Volume (20 Days)	304,563

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, XRF Scientific had revenue of AUD 60.12 million and earned 8.89 million in profits. Earnings per share was 0.06.

Revenue	60.12M
Gross Profit	26.55M
Operating Income	13.74M
Pretax Income	13.46M
Net Income	8.89M
EBITDA	14.46M
EBIT	13.74M
Earnings Per Share (EPS)	0.06

Full Income Statement

Balance Sheet

The company has 12.05 million in cash and 4.69 million in debt, giving a net cash position of 7.35 million or 0.05 per share.

Cash & Cash Equivalents	12.05M
Total Debt	4.69M
Net Cash	7.35M
Net Cash Per Share	0.05
Equity (Book Value)	55.54M
Book Value Per Share	0.40
Working Capital	28.75M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.09 million and capital expenditures -1.61 million, giving a free cash flow of 6.48 million.

Operating Cash Flow	8.09M
Capital Expenditures	-1.61M
Free Cash Flow	6.48M
FCF Per Share	0.05

Full Cash Flow Statement

Margins

Gross margin is 44.16%, with operating and profit margins of 22.86% and 14.78%.

Gross Margin	44.16%
Operating Margin	22.86%
Pretax Margin	22.40%
Profit Margin	14.78%
EBITDA Margin	24.06%
EBIT Margin	22.86%
FCF Margin	10.78%

Dividends & Yields

This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 2.17%.

Dividend Per Share	0.04
Dividend Yield	2.17%
Dividend Growth (YoY)	18.18%
Years of Dividend Growth	6
Payout Ratio	40.52%
Buyback Yield	-0.80%
Shareholder Yield	1.37%
Earnings Yield	3.56%
FCF Yield	2.56%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

XRF Scientific has an Altman Z-Score of 10.4.

Altman Z-Score	10.4
Piotroski F-Score	n/a